Clinical Trials for Askgene Pharma

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Askgene Pharma

Clinical Trials (5)

NCT06206733
ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma
PHASE3Recruiting
780 participants
Started: Jan 25, 2024 · Completed: Dec 30, 2028
2 conditions2 sponsors1 location
NCT05940428
A Study of ASKG712 in Patients With Diabetic Macular Edema
PHASE1Active, not recruiting
26 participants
Started: Oct 23, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05867420
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
PHASE1Recruiting
104 participants
Started: Aug 3, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT05632939
ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer.
PHASE1/PHASE2Active, not recruiting
62 participants
Started: Feb 21, 2023 · Completed: Feb 10, 2026
2 conditions2 sponsors1 location
NCT05456828
A Study of ASKG712 in Patients With Neovascular Age-Related Macular Degeneration
PHASE1Active, not recruiting
56 participants
Started: Feb 10, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location